Line 83: |
Line 83: |
| | | | | |
| |- | | |- |
− | |Juvenile myelomonocytic leukaemia||Disease|| '''Sarah Rapisardo, PhD, FACMG''' |Assistant Professor, Pathology Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories|| || || || ||FQR|| || | + | |Juvenile myelomonocytic leukaemia||Disease|| '''Sarah Rapisardo, PhD, FACMG''' | || || || || ||FQR|| || |
| + | |Juvenile Myelomonocytic Leukemia (JMML) |
| + | |<nowiki>Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology</nowiki> |
| + | |
| + | Associate Director | Division of Molecular Pathology, Genetics and Genomics |
| + | |
| + | Duke University Health System Clinical Laboratories |
| + | |PENDING importing content and reference formatting |
| | | | | |
− | | | + | |FQR has emailed SR several times, last 4/20/22 |
− | |
| |
− | |
| |
− | |PENDING importing content and reference formatting; FQR has emailed SR several times, last 4/20/22
| |
| |- | | |- |
− | |Myeloproliferative neoplasm, NOS||Disease||Thomas Lee, MD, PhD, University of California, Los Angeles|| || || || ||FQR|| || | + | |Myeloproliferative neoplasm, NOS||Disease|| || || || || ||FQR|| || |
− | | | + | |Myeloproliferative Neoplasm (MPN), Unclassifiable |
− | | | + | |Thomas Lee, MD, PhD, University of California, Los Angeles |
− | | | + | |Complete |
| | | | | |
| | | | | |